Skip to main content

Table 1 Baseline clinical and pathologic characteristics of patients

From: Morbidity and oncologic outcome after saphenous vein-sparing inguinal lymphadenectomy in melanoma patients

  

Overall

(%)

SaphRes

(%)

SaphSpar

(%)

p value

Patients

 No. of patients

 

106

 

65

(61.3)

41

(38.7)

 

 Male sex

 

49

(46.2)

30

(46.2)

19

(46.3)

0.9849

 Age

[years]

58.3

 

59.7

 

56.2

 

0.2239

 BMI

[kg/m2]

26.9

 

26.8

 

27.2

 

0.4902

Risk factors

 Nicotine abuse

 

24

(22.6)

12

(18.5)

12

(29.3)

0.1954

 Diabetes mellitus

 

9

(8.5)

5

(7.7)

4

(9.8)

0.7105

 Arterial hypertonia

 

49

(46.2)

30

(46.2)

19

(46.3)

0.9849

Surgical procedure

 Mean duration

[min]

87.0

 

83.9

 

91.8

 

0.2955

 Mean hospital stay

[days]

12.0

 

11.6

 

12.6

 

0.6372

 Mean no. resected LN

 

8.6

 

9.0

 

7.9

 

0.2318

Primary tumor characteristics

Location

 Located at limb

 

81

(76.4)

50

(76.9)

31

(75.6)

 

 Located at trunk

 

18

(17.0)

10

(15.4)

8

(19.5)

0.7560a

 Unknown

 

7

(6.6)

5

(7.7)

2

(4.9)

 

Melanoma subtype

 SSM

 

45

(42.5)

25

(38.5)

20

(48.8)

 

 NM

 

16

(15.1)

11

(16.9)

5

(12.2)

0.7303b

 Other

 

35

(33.0)

23

(35.4)

12

(29.3)

 

 Unknown

 

10

(9.4)

6

(9.2)

4

(9.8)

 

T stage

 pT1

 

9

(8.5)

5

(7.7)

4

(9.8)

 

 pT2

 

26

(24.5)

16

(24.6)

10

(24.4)

 

 pT3

 

24

(22.6)

14

(21.5)

10

(24.4)

0.9763c

 pT4

 

21

(19.8)

14

(21.5)

7

(17.1)

 

 Unknown

 

26

(24.5)

16

(24.6)

10

(24.4)

 

Ulcerated

 

44

(41.9)

29

(44.6)

15

(37.5)

0.4730

Mean thickness

[mm]

3.5

 

4.5

 

3.1

 

0.3542

Lymph node status

 Positive SLN

 

53

(50.0)

30

(46.2)

23

(56.1)

0.3187

 Positive non-sentinel LN

 

51

(48.1)

31

(47.7)

20

(48.8)

0.9130

 Positive LN statusd

 

89

(84.0)

53

(81.5)

36

(87.8)

0.3919

Follow-up

 Mean

[months]

38.6

 

29.5

 

53.1

 

0.0006

  1. aLocation: "Located at limb" vs. "Located at trunk" vs. "Unknown"
  2. bMelanoma subtype: "SSM" vs. "NM" vs. "Other" vs. "Unknown"
  3. cT-Stage: "pT1" vs. "pT2" vs. "pT3" vs. "pT4" vs. "Unkown"
  4. dPositive SLN or positive non-sentinel LN
  5. no. number, SaphRes V. saphena magna resection, SaphSpar V. saphena magna sparing, BMI body mass index, SSM superficial spreading melanoma, NM nodular melanoma, SLN sentinel lymph node, LN lymph node